Transcriptome analysis in a primary human muscle cell differentiation model for myotonic dystrophy type 1
Affiliation
Department of Neurology, Friedrich-Baur-Institute, LMU Klinikum, Ludwig-Maximilians-University Munich, 80336 Munich, GermanyIssue Date
2021
Metadata
Show full item recordAbstract
Myotonic dystrophy type 1 (DM1) is caused by CTG-repeat expansions leading to a complex pathology with a multisystemic phenotype that primarily affects the muscles and brain. Despite a multitude of information, especially on the alternative splicing of several genes involved in the pathology, information about additional factors contributing to the disease development is still lacking. We performed RNAseq and gene expression analyses on proliferating primary human myoblasts and differentiated myotubes. GO-term analysis indicates that in myoblasts and myotubes, different molecular pathologies are involved in the development of the muscular phenotype. Gene set enrichment for splicing reveals the likelihood of whole, differentiation stage specific, splicing complexes that are misregulated in DM1. These data add complexity to the alternative splicing phenotype and we predict that it will be of high importance for therapeutic interventions to target not only mature muscle, but also satellite cells.Citation
Todorow V, Hintze S, Kerr ARW, Hehr A, Schoser B, Meinke P. Transcriptome Analysis in a Primary Human Muscle Cell Differentiation Model for Myotonic Dystrophy Type 1. IJMS. 2021 Aug 10;22(16):8607.Journal
International Journal of Molecular SciencesDOI
10.3390/ijms22168607PubMed ID
34445314Additional Links
https://dx.doi.org/10.3390/ijms22168607Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.3390/ijms22168607
Scopus Count
Collections
Related articles
- Normal myogenesis and increased apoptosis in myotonic dystrophy type-1 muscle cells.
- Authors: Loro E, Rinaldi F, Malena A, Masiero E, Novelli G, Angelini C, Romeo V, Sandri M, Botta A, Vergani L
- Issue date: 2010 Aug
- Recovery in the Myogenic Program of Congenital Myotonic Dystrophy Myoblasts after Excision of the Expanded (CTG)n Repeat.
- Authors: André LM, van Cruchten RTP, Willemse M, Bezstarosti K, Demmers JAA, van Agtmaal EL, Wansink DG, Wieringa B
- Issue date: 2019 Nov 13
- Ameliorated cellular hallmarks of myotonic dystrophy in hybrid myotubes from patient and unaffected donor cells.
- Authors: Raaijmakers RHL, Ausems CRM, Willemse M, Cumming SA, van Engelen BGM, Monckton DG, van Bokhoven H, Wansink DG
- Issue date: 2024 Sep 15
- Transcriptome Analysis Reveals Altered Inflammatory Pathway in an Inducible Glial Cell Model of Myotonic Dystrophy Type 1.
- Authors: Azotla-Vilchis CN, Sanchez-Celis D, Agonizantes-Juárez LE, Suárez-Sánchez R, Hernández-Hernández JM, Peña J, Vázquez-Santillán K, Leyva-García N, Ortega A, Maldonado V, Rangel C, Magaña JJ, Cisneros B, Hernández-Hernández O
- Issue date: 2021 Jan 26
- hnRNP L is essential for myogenic differentiation and modulates myotonic dystrophy pathologies.
- Authors: Alexander MS, Hightower RM, Reid AL, Bennett AH, Iyer L, Slonim DK, Saha M, Kawahara G, Kunkel LM, Kopin AS, Gupta VA, Kang PB, Draper I
- Issue date: 2021 Jun